Clinical Trials

NCT03911531 | COMPLETED

55 participants

Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2019-01-15

Completion:

2025-12-30

Conditions

• Nonimmune Fetal Hydrops
• Nonimmune Hydrops in Neonate
• Genetic Disorders

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT03865589 | COMPLETED | NA

250 participants

Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2019-04-01

Completion:

2025-12-31

Conditions

• Bone Marrow Transplant Complications
• Sinusoidal Obstruction Syndrome
• Veno Occlusive Disease, Hepatic
• Stem Cell Transplant Complications

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT03847649 | RECRUITING | PHASE2

60 participants

A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2020-03-09

Completion:

2030-04-30

Conditions

• Cancer

Interventions

• DRUG

No Results Yet

NCT03816163 | ACTIVE_NOT_RECRUITING | PHASE2

393 participants

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2019-03-15

Completion:

2026-08-31

Conditions

• Pancreatic Cancer
• Metastatic Pancreatic Cancer
• Metastatic Pancreatic Adenocarcinoma

Interventions

• DRUG

No Results Yet

NCT03716531 | ACTIVE_NOT_RECRUITING | NA

199 participants

Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2019-03-19

Completion:

2026-08-26

Conditions

• Pancreas Cancer

Interventions

• RADIATION

No Results Yet

NCT03712566 | ACTIVE_NOT_RECRUITING

39 participants

Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2018-11-06

Completion:

2027-07-31

Conditions

• Cancer
• Esophagus Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Head and Neck
• Anal Canal Squamous Cell Carcinoma
• Metastatic Cancer

No Results Yet

NCT03705897 | COMPLETED | NA

9264 participants

PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2013-08-31

Completion:

2016-09-30

Conditions

• ColoRectal Cancer

Interventions

• OTHER

No Results Yet

NCT03627104 | COMPLETED | NA

80 participants

Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2018-09-03

Completion:

2020-01-01

Conditions

• Obesity
• Insulin Resistance

Interventions

• DIETARY_SUPPLEMENT

No Results Yet

NCT03603457 | ACTIVE_NOT_RECRUITING

2842 participants

OFSEP High Definition Cohort

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2018-07-10

Completion:

2027-12-31

Conditions

• Multiple Sclerosis

No Results Yet

NCT03519971 | COMPLETED | PHASE3

328 participants

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2018-03-29

Completion:

2023-09-07

Conditions

• Non-Small Cell Lung Cancer

Interventions

• DRUG
• OTHER
• RADIATION

Results Available

NCT03458780 | COMPLETED

6 participants

Yellow Fever Immune Response at Single Cell Resolution

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2016-08-22

Completion:

2018-09-05

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT03391362 | ACTIVE_NOT_RECRUITING | NA

100 participants

Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2018-02-23

Completion:

2024-04-10

Conditions

• Brain Metastases
• Small Cell Lung Cancer

Interventions

• RADIATION

Results Available

NCT03374267 | RECRUITING

2230 participants

Registry Platform Urologic Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2017-12-07

Completion:

2034-03-31

Conditions

• Renal Cell Carcinoma
• Urothelial Carcinoma

Interventions

• OTHER

No Results Yet

NCT03328273 | ACTIVE_NOT_RECRUITING | PHASE1

12 participants

A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2018-01-31

Completion:

2021-09-07

Conditions

• Chronic Lymphocytic Leukemia

Interventions

• DRUG

No Results Yet

NCT03322345 | TERMINATED

3 participants

Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2019-04-09

Completion:

2025-05-01

Conditions

• Dopamine
• Protein-Losing Enteropathies
• Lymphatic System
• Lymph
• Catecholamine
• Single-ventricle
• Congenital Heart Disease

No Results Yet

NCT03298802 | TERMINATED | PHASE3

453 participants

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2017-11-21

Completion:

2025-04-22

Conditions

• Pre-Eclampsia
• Gestational Hypertension
• Superimposed Pre-Eclampsia
• Hypertension, Pregnancy-Induced
• Postpartum Pregnancy-Induced Hypertension
• Postpartum Preeclampsia

Interventions

• DRUG

Results Available

NCT03242161 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1

8 participants

Development of LabPatch-alcohol as a Noninvasive Skin Patch to Detect Blood Alcohol Concentrations

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2018-01-01

Completion:

2026-12-11

Conditions

• Alcohol Intoxication

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT03228290 | RECRUITING

5000 participants

Functional Assessment in Liver Transplantation

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2011-10-12

Completion:

2030-12-31

Conditions

• End Stage Liver Disease

No Results Yet

NCT03091192 | ACTIVE_NOT_RECRUITING | PHASE3

60 participants

Savolitinib vs. Sunitinib in MET-driven PRCC.

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2017-07-25

Completion:

2019-08-18

Conditions

• Carcinoma
• Carcinoma, Renal Cell
• Kidney Neoplasms
• Urologic Neoplasms
• Kidney Diseases
• Neoplasms by Site
• Enzyme Inhibitors
• Protein Kinase Inhibitors

Interventions

• DRUG

Results Available

NCT03076008 | ACTIVE_NOT_RECRUITING

201 participants

The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2016-10-01

Completion:

2023-03-31

Conditions

• Patellar Dislocation

Interventions

• OTHER

No Results Yet

NCT02864992 | ACTIVE_NOT_RECRUITING | PHASE2

337 participants

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2016-09-13

Completion:

2022-05-16

Conditions

• Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification
• Lung Adenocarcinoma Stage IIIB/IV

Interventions

• DRUG

Results Available

NCT02752035 | COMPLETED | PHASE3

183 participants

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2016-08-01

Completion:

2023-03-10

Conditions

• Acute Myeloid Leukemia (AML)
• Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation

Interventions

• DRUG

Results Available

NCT02734004 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

264 participants

A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2016-03-17

Completion:

2021-09-17

Conditions

• Ovarian
• Breast
• SCLC
• Gastric Cancers

Interventions

• DRUG

Results Available

NCT02724488 | COMPLETED

14 participants

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2015-04-30

Completion:

2026-01-31

Conditions

• Head and Neck Cancer
• Melanoma

No Results Yet

NCT02717624 | ACTIVE_NOT_RECRUITING | PHASE1

72 participants

A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2016-04-20

Completion:

2022-06-15

Conditions

• Mantle Cell Lymphoma (MCL)

Interventions

• DRUG

No Results Yet

NCT02677974 | ACTIVE_NOT_RECRUITING

510 participants

On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2015-11-10

Completion:

2027-04-30

Conditions

• Thrombotic and Bleeding Events

Interventions

• DEVICE

No Results Yet

NCT02671448 | ACTIVE_NOT_RECRUITING | NA

83 participants

Pilot Trial of Homebound Stem Cell Transplantation

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2016-01-31

Completion:

2027-01-31

Conditions

• Plasma Cell Dyscrasia

Interventions

• BEHAVIORAL

No Results Yet

NCT02516241 | ACTIVE_NOT_RECRUITING | PHASE3

1126 participants

Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2015-11-02

Completion:

2020-01-27

Conditions

• Urothelial Cancer

Interventions

• DRUG

Results Available

NCT02474368 | ACTIVE_NOT_RECRUITING | PHASE1

21 participants

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2015-11-30

Completion:

2021-01-31

Conditions

• Recurrent Head and Neck Carcinoma
• Head and Neck Cancer Metastatic
• Head or Neck Cancer

Interventions

• DRUG
• RADIATION

No Results Yet

NCT02395497 | RECRUITING | PHASE2/PHASE3

60 participants

Human Penile Allotransplantation

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2014-06-30

Completion:

2034-06-30

Conditions

• Amputation
• Wounds and Injuries
• Amputation, Traumatic
• Urologic Surgical Procedures, Male
• Amputation, Traumatic/Surgery
• Penis/Transplantation
• Penis/Surgery
• Penis/Injuries
• Congenital Anomaly, Male Genitalia

Interventions

• DRUG
• PROCEDURE
• BIOLOGICAL

No Results Yet

NCT02240472 | ACTIVE_NOT_RECRUITING | NA

2766 participants

Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2015-01-27

Completion:

2021-12-31

Conditions

• Breast Cancer

Interventions

• PROCEDURE

No Results Yet

NCT02032823 | ACTIVE_NOT_RECRUITING | PHASE3

1837 participants

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2014-04-22

Completion:

2020-03-27

Conditions

• Breast Cancer

Interventions

• DRUG

Results Available

NCT01964157 | COMPLETED | PHASE2

32 participants

An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2013-09-01

Completion:

2026-01-29

Conditions

• Non-small Cell Lung Cancer (NSCLC)

Interventions

• DRUG

No Results Yet

NCT01922440 | COMPLETED

1339 participants

A Registry for Participants With Chronic Hypoparathyroidism

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2013-07-30

Completion:

2026-06-30

Conditions

• Hypoparathyroidism

Interventions

• OTHER

No Results Yet

NCT01782599 | ACTIVE_NOT_RECRUITING | NA

125 participants

Electronic Cigarettes and Reactivity to Smoking Cues

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2013-01-31

Completion:

2027-03-24

Conditions

• Nicotine Dependence

Interventions

• OTHER

No Results Yet

NCT01505400 | ACTIVE_NOT_RECRUITING

3026 participants

Integrated Molecular Profiling in Advanced Cancers Trial

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-14

Start Date:

2012-02-29

Completion:

2027-07-31

Conditions

• Breast Cancer
• Non-small Cell Lung Cancer
• Colorectal Cancer
• Genitourinary Cancer
• Pancreatobiliary Gastrointestinal Cancer
• Upper Aerodigestive Tract Cancer
• Gynecological Cancers
• Melanoma Cancers
• Rare Cancers
• Unknown Primary Cancers

No Results Yet

NCT01171651 | COMPLETED | PHASE2

25 participants

A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2009-05-26

Completion:

2012-09-27

Conditions

• Carcinoma, Hepatocellular

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT01116648 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

155 participants

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2010-04-14

Completion:

2018-10-31

Conditions

• Fallopian Tube Carcinoma
• Ovarian Endometrioid Adenocarcinoma
• Ovarian High Grade Serous Adenocarcinoma
• Ovarian Serous Adenocarcinoma
• Ovarian Serous Surface Papillary Adenocarcinoma
• Primary Peritoneal Serous Adenocarcinoma
• Triple-Negative Breast Carcinoma

Interventions

• PROCEDURE
• DRUG

Results Available

NCT01096602 | COMPLETED | PHASE2

63 participants

Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2010-05-31

Completion:

2023-12-31

Conditions

• Acute Myelogenous Leukemia
• AML

Interventions

• BIOLOGICAL

Results Available

NCT00840853 | ACTIVE_NOT_RECRUITING | PHASE1

68 participants

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-14

Start Date:

2009-04-30

Completion:

2016-04-30

Conditions

• Acute Lymphoblastic Leukemia (ALL)
• Chronic Lymphocytic Leukemia (CLL)
• Non Hodgkin's Lymphoma

Interventions

• GENETIC
• DRUG

No Results Yet